$LEGN rose 6.3% after filing its 2026 AGM proxy form

Legend Biotech (LEGN) shares rose 6.3% on Aug 18, 2026 after the company published a final “Form of Proxy” tied to its 2026 annual general meeting (AGM).

What Legend Biotech announced

Legend Biotech released the final version of its 2026 AGM “Form of Proxy.” In plain English, it’s the voting paperwork that lets shareholders appoint someone (often the meeting chair) to vote on their behalf at the annual meeting. The document is designed to cover “all matters and resolutions” that will be put to shareholders at the AGM. The filing also specifies that the AGM is scheduled to be held on the 24th day of the month referenced in the document.

What it means for Legend Biotech

Proxy materials are a core part of the company’s shareholder-governance process, and a “final” proxy form suggests the meeting mechanics are being locked in. By laying out how votes can be cast via proxy, the company could be aiming to make participation easier for shareholders who won’t attend in person. The filing also signals that the company is moving forward with its annual meeting agenda, where shareholder approvals may be required for certain corporate actions. Beyond that, the proxy form itself is procedural — it’s about how decisions get voted on, not a direct update on operations.

How the stock reacted

LEGN moved higher quickly and kept its gains through the close.

Window	Move
5 min	+1.3%
10 min	+0.7%
30 min	+0.6%
1 hour	+0.8%
end of day	+6.3%

On a market-adjusted basis, the stock’s same-day move was +6.4% versus SPY.